Table: Peptidream - 9-MTH parent results
May 14 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Mar 31, 2018 Mar 31, 2017 Jun 30, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.14 1.42
(-19.8 pct) (-47.1 pct)
Operating loss 1.33 107 mln
(-93.0 pct)
Recurring loss 1.19 235 mln
(-83.5 pct)
Net loss 831 mln 164 mln
(-83.2 pct)
EPS loss 6.93 yen 1.44 yen
EPS Diluted 1.27 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner